Expression profiles of LOX, LOXL1, LOXL2, LOXL3, and LOXL4 in the TCGA cohort were also evaluated in low grade astrocytic glioma (LGG), encompassing AG2 and AG3, according to IDH mutation status and for GBM cases (Figure 1C). This evidence concerns the gene LOXL3 and glioblastoma.